“Snake-oil,” “quack medicine,” and “industrially cultured organisms:” biovalue and the commercialization of human microbiome research [Book Review]
BMC Medical Ethics 13 (1):28- (2012)
AbstractBackground Continued advances in human microbiome research and technologies raise a number of ethical, legal, and social challenges. These challenges are associated not only with the conduct of the research, but also with broader implications, such as the production and distribution of commercial products promising maintenance or restoration of good physical health and disease prevention. In this article, we document several ethical, legal, and social challenges associated with the commercialization of human microbiome research, focusing particularly on how this research is mobilized within economic markets for new public health uses. Methods We conducted in-depth, semi-structured interviews (2009–2010) with 63 scientists, researchers, and National Institutes of Health project leaders (“investigators”) involved with human microbiome research. Interviews explored a range of ethical, legal, and social dimensions of human microbiome research, including investigators’ perspectives on commercialization. Using thematic content analysis, we identified and analyzed emergent themes and patterns. Results Investigators discussed the commercialization of human microbiome research in terms of (1) commercialization, probiotics, and issues of safety, (2) public awareness of the benefits and risks of dietary supplements, and (3) regulation. Conclusion The prevailing theme of ethical, legal, social concern focused on the need to find a balance between the marketplace, scientific research, and the public’s health. The themes we identified are intended to serve as points for discussions about the relationship between scientific research and the manufacture and distribution of over-the-counter dietary supplements in the United States
Similar books and articles
Human Tissue Research. A European Perspective on the Ethical and Legal Challenges.Christian Lenk, Nils Hoppe, Katharian Beier & Claudia Wiesemann (eds.) - 2011 - Oxford University Press.
Research on Human Subjects: Ethics, Law and Social Policy.David N. Weisstub (ed.) - 1998 - Pergamon Press.
The Commercialization of Human Stem Cells: Ethical and Policy Issues. [REVIEW]David B. Resnik - 2002 - Health Care Analysis 10 (2):127-154.
Intellectual Property and the Commercialization of Research and Development.Vincent Norcia - 2005 - Science and Engineering Ethics 11 (2):203-219.
Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary.Ezekiel J. Emanuel (ed.) - 2003 - Johns Hopkins University Press.
Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies.Anna C. Mastroianni, Ruth R. Faden & Daniel D. Federman (eds.) - 1994 - National Academy Press.
Responsible Conduct in Nanomedicine Research: Environmental Concerns Beyond the Common Rule.David B. Resnik - 2012 - Journal of Law, Medicine and Ethics 40 (4):848-855.
Human Rights,Cultural Pluralism, and International Health Research.Patricia A. Marshall - 2005 - Theoretical Medicine and Bioethics 26 (6):529-557.
The Ethics and Politics of Human Experimentation.Paul Murray McNeill - 1993 - Cambridge University Press.
Ethical Issues in Tissue Banking for Research: A Brief Review of Existing Organizational Policies.Keith Bauer, Sara Taub & Kayhan Parsi - 2004 - Theoretical Medicine and Bioethics 25 (2):113-142.
Added to PP
Historical graph of downloads
Citations of this work
The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts.Brent Daniel Mittelstadt & Luciano Floridi - 2016 - Science and Engineering Ethics 22 (2):303–341.
Navigating Social and Ethical Challenges of Biobanking for Human Microbiome Research.Kieran C. O’Doherty, David S. Guttman, Yvonne C. W. Yau, Valerie J. Waters, D. Elizabeth Tullis, David M. Hwang & Kim H. Chuong - 2017 - BMC Medical Ethics 18 (1):1.
Gut Health in the Era of the Human Gut Microbiota: From Metaphor to Biovalue.Vincent Baty, Bruno Mougin, Catherine Dekeuwer & Gérard Carret - 2014 - Medicine, Health Care and Philosophy 17 (4):579-597.
References found in this work
From Evidence-Based Medicine to Marketing-Based Medicine: Evidence From Internal Industry Documents. [REVIEW]Glen I. Spielmans & Peter I. Parry - 2010 - Journal of Bioethical Inquiry 7 (1):13-29.